Mirae Asset Global ETFs Holdings
AXSM icon

Mirae Asset Global ETFs Holdings’s Axsome Therapeutics AXSM Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.29M Buy
19,452
+420
+2% +$72.5K ﹤0.01% 972
2025
Q4 		$3.48M Buy
19,032
+230
+1% +$32.1K 0.01% 930
2025
Q3 		$2.28M Sell
18,802
-3,381
-15% -$381K ﹤0.01% 1085
2025
Q2 		$2.32M Buy
22,183
+260
+1% +$27.5K ﹤0.01% 1029
2025
Q1 		$2.56M Buy
21,923
+1,002
+5% +$114K 0.01% 1006
2024
Q4 		$1.77M Buy
20,921
+986
+5% +$90.7K ﹤0.01% 1206
2024
Q3 		$1.79M Buy
19,935
+2,038
+11% +$178K ﹤0.01% 1196
2024
Q2 		$1.44M Buy
+17,897
New +$1.33M ﹤0.01% 1247

Other funds holding AXSM

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return